IL150048A0 - Enzyme treatment for infection - Google Patents

Enzyme treatment for infection

Info

Publication number
IL150048A0
IL150048A0 IL15004800A IL15004800A IL150048A0 IL 150048 A0 IL150048 A0 IL 150048A0 IL 15004800 A IL15004800 A IL 15004800A IL 15004800 A IL15004800 A IL 15004800A IL 150048 A0 IL150048 A0 IL 150048A0
Authority
IL
Israel
Prior art keywords
infection
enzyme treatment
enzyme
treatment
Prior art date
Application number
IL15004800A
Other languages
English (en)
Original Assignee
Chemgen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22617824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL150048(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chemgen Corp filed Critical Chemgen Corp
Publication of IL150048A0 publication Critical patent/IL150048A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04011—Phosphoinositide phospholipase C (3.1.4.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Animal Husbandry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL15004800A 1999-12-10 2000-12-08 Enzyme treatment for infection IL150048A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16993599P 1999-12-10 1999-12-10
PCT/US2000/033466 WO2001041785A2 (en) 1999-12-10 2000-12-08 Enzyme treatment for infection

Publications (1)

Publication Number Publication Date
IL150048A0 true IL150048A0 (en) 2002-12-01

Family

ID=22617824

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15004800A IL150048A0 (en) 1999-12-10 2000-12-08 Enzyme treatment for infection
IL150048A IL150048A (en) 1999-12-10 2002-06-05 Preparations of enzymes to treat or reduce the risk of gastrointestinal infection

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL150048A IL150048A (en) 1999-12-10 2002-06-05 Preparations of enzymes to treat or reduce the risk of gastrointestinal infection

Country Status (31)

Country Link
US (2) US6780628B2 (es)
EP (1) EP1239872B1 (es)
JP (1) JP4871473B2 (es)
KR (1) KR100639746B1 (es)
CN (3) CN101327320A (es)
AR (2) AR026764A1 (es)
AT (1) ATE481981T1 (es)
AU (1) AU782831B2 (es)
BR (1) BRPI0016231B8 (es)
CA (1) CA2394856C (es)
CL (1) CL2008000057A1 (es)
CO (1) CO5280226A1 (es)
CR (1) CR6674A (es)
CZ (1) CZ304925B6 (es)
DE (1) DE60045010D1 (es)
DK (1) DK1239872T3 (es)
ES (1) ES2353371T3 (es)
HU (1) HU230301B1 (es)
IL (2) IL150048A0 (es)
IN (1) IN247731B (es)
MX (1) MX264033B (es)
MY (1) MY124714A (es)
NZ (1) NZ519404A (es)
PH (1) PH12000003381B1 (es)
PL (1) PL203054B1 (es)
PT (1) PT1239872E (es)
RU (1) RU2272419C2 (es)
SK (1) SK287956B6 (es)
TW (1) TWI255189B (es)
UA (1) UA78486C2 (es)
WO (1) WO2001041785A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US7247299B2 (en) * 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
EP1812550A2 (en) * 2004-10-20 2007-08-01 Iogenetics, Llc Biocides
EP1880733A4 (en) 2005-04-25 2009-08-12 Genkin Dmitry Dmitrievich METHOD FOR EXTENDING THE LIFE OF A HUMAN AND ANIMALS
ES2361819T3 (es) * 2005-12-15 2011-06-22 Chemgen Corporation Enzimas para reducir el estrés inmunológico.
EP2095825B8 (en) 2006-11-28 2012-03-28 CLS Therapeutics Limited Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method
RU2474587C2 (ru) * 2007-06-08 2013-02-10 Острэйлиан Паултри Срс Пти Лтд КЛОСТРИДИАЛЬНЫЙ ТОКСИН NetB
DK2225356T3 (en) * 2007-12-20 2014-11-17 Danisco Us Inc Enzymatic prevention and control of biofilm
PL2254591T3 (pl) 2008-02-08 2018-01-31 Prothera Inc Inhibicja i leczenie biofilmów żołądkowo-jelitowych
CN104114036B (zh) 2012-02-16 2016-05-18 伊莱利利公司 用于减少动物废物的环境影响的方法和组合物
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
TWI656872B (zh) 2014-11-13 2019-04-21 美商益農美國公司 甲基鹽黴素於豬飼料中之抗病毒效果
JP6745873B2 (ja) 2015-05-22 2020-08-26 ドミトリエヴィッチ ゲンキン，ドミトリー 神経変性における治療標的としての細胞外ｄｎａ
CN106119221A (zh) * 2016-06-28 2016-11-16 浙江省农业科学院 磷脂酰肌醇特异性磷脂酶c基因、载体、工程菌及应用
CN106318925B (zh) * 2016-08-19 2021-04-02 浙江省农业科学院 利用枯草芽孢杆菌高效表达pi-plc基因的方法
CN106615691B (zh) * 2016-10-11 2019-07-02 上海国龙生物技术集团有限公司 一种抗感染酶复合剂及其在饲料中的应用
US10501730B2 (en) * 2017-05-30 2019-12-10 Ab Enzymes Oy Mannanase variants
EP3740581A4 (en) 2018-01-16 2021-10-27 CLS Therapeutics Limited TREATMENT OF DISEASES BY LIVER EXPRESSION OF AN ENZYME WITH DESOXYRIBONUCLEASE (DNASE) ACTIVITY
MX2020009045A (es) * 2018-03-02 2020-10-12 Evonik Operations Gmbh Procedimiento in vitro para detectar disfuncion de la barrera intestinal en animales mediante la determinacion de ovotransferrina.
RU2720471C1 (ru) * 2019-03-21 2020-04-30 Федеральное Государственное бюджетное научное учреждение "Федеральный научный центр биологических систем и агротехнологий российской академии наук" Кормовая добавка для цыплят-бройлеров

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
JPS5534039A (en) 1978-08-30 1980-03-10 Hiroo Ikezawa Preparation of phsophatidylinositol phospholipase c from bacillus thuringiensis
WO1987000196A1 (en) 1985-07-09 1987-01-15 Quadrant Bioresources Limited Protection of proteins and the like
US4877738A (en) 1986-07-25 1989-10-31 Wisconsin Alumni Research Foundation Biological control of damping off and root rot and inoculum preparation therefor
US5049379A (en) 1987-07-27 1991-09-17 Wisconsin Alumni Research Foundation Fungicidal toxin and method and inoculum for controlling root rot and damping off
JPH0338530A (ja) * 1989-07-03 1991-02-19 Ajinomoto Co Inc 抗真菌剤
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
WO1991018521A1 (en) * 1990-05-29 1991-12-12 Chemgen Corporation Hemicellulase supplement to improve the energy efficiency of hemicellulose-containing food and animal feed
EP0477739A3 (en) * 1990-09-27 1992-12-09 F. Hoffmann-La Roche Ag Glycosyl-phosphatidylinositol-specific phospholipase d
JPH07184642A (ja) * 1993-12-27 1995-07-25 Toagosei Co Ltd ホスホリパーゼｃの生産方法
EP0743017B1 (en) * 1995-05-15 2004-09-29 DSM IP Assets B.V. Application of phospholipases in animal feed
NL1003096C2 (nl) 1995-05-15 1996-11-19 Gist Brocades Bv Application of phospholipases in animal feed.
JPH08332032A (ja) * 1995-06-12 1996-12-17 Showa Denko Kk 動物経口物用酵素剤及びその用途
JP3914585B2 (ja) * 1995-10-19 2007-05-16 イーエヌ大塚製薬株式会社 マクロファージ一酸化窒素産生亢進剤
CN1092495C (zh) 1996-05-03 2002-10-16 开姆根有限公司 半纤维素酶在低热焓饲料中的应用
US6162473A (en) * 1996-05-03 2000-12-19 Chemgen Corporation Hemicellulase use in feeds with low caloric content
JPH1045581A (ja) * 1996-07-29 1998-02-17 Hideyo Yamaguchi 好中球機能低下抑制剤又は感染防御剤
CN1235636A (zh) * 1996-10-31 1999-11-17 诺沃挪第克公司 新型磷脂酶,及其生产和应用
IL142384A0 (en) 1998-10-15 2002-03-10 Dsm Nv Antimicrobial enzymes in animal feed
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US20020116029A1 (en) * 2001-02-20 2002-08-22 Victor Miller MRI-compatible pacemaker with power carrying photonic catheter and isolated pulse generating electronics providing VOO functionality

Also Published As

Publication number Publication date
CN102172262B (zh) 2014-03-05
HUP0203402A2 (hu) 2003-02-28
NZ519404A (en) 2004-05-28
AR089799A2 (es) 2014-09-17
AR026764A1 (es) 2003-02-26
CA2394856C (en) 2011-05-10
RU2272419C2 (ru) 2006-03-27
BRPI0016231B8 (pt) 2021-05-25
PH12000003381B1 (en) 2010-04-16
IL150048A (en) 2016-09-29
HUP0203402A3 (en) 2004-12-28
EP1239872A2 (en) 2002-09-18
DK1239872T3 (da) 2010-10-25
KR100639746B1 (ko) 2006-10-30
CO5280226A1 (es) 2003-05-30
US20020048576A1 (en) 2002-04-25
US20040223961A1 (en) 2004-11-11
PT1239872E (pt) 2010-12-03
KR20020069204A (ko) 2002-08-29
PL356175A1 (en) 2004-06-14
CR6674A (es) 2007-02-22
MX264033B (es) 2009-01-22
MY124714A (en) 2006-06-30
AU782831B2 (en) 2005-09-01
BR0016231A (pt) 2003-06-24
ATE481981T1 (de) 2010-10-15
CN102172262A (zh) 2011-09-07
IN2002DE00585A (es) 2009-03-20
AU2577601A (en) 2001-06-18
PL203054B1 (pl) 2009-08-31
MXPA02005735A (es) 2003-10-14
CA2394856A1 (en) 2001-06-14
US7723091B2 (en) 2010-05-25
JP2003520207A (ja) 2003-07-02
TWI255189B (en) 2006-05-21
DE60045010D1 (de) 2010-11-04
US6780628B2 (en) 2004-08-24
CN1433319A (zh) 2003-07-30
EP1239872B1 (en) 2010-09-22
BRPI0016231B1 (pt) 2016-10-04
UA78486C2 (uk) 2007-04-10
CL2008000057A1 (es) 2008-03-14
SK8262002A3 (en) 2002-12-03
CZ20022007A3 (cs) 2002-11-13
CN101327320A (zh) 2008-12-24
ES2353371T3 (es) 2011-03-01
SK287956B6 (sk) 2012-07-03
IN247731B (es) 2011-05-13
JP4871473B2 (ja) 2012-02-08
WO2001041785A3 (en) 2002-01-24
WO2001041785A2 (en) 2001-06-14
CZ304925B6 (cs) 2015-01-28
HU230301B1 (hu) 2015-12-28

Similar Documents

Publication Publication Date Title
IL150048A0 (en) Enzyme treatment for infection
GB9928968D0 (en) Enzyme
ZA200108446B (en) Novel method of treatment.
HUP0201117A3 (en) Attenuated microorganisms for the treatment of infection
AU5215300A (en) Dental treatment area
GB9925136D0 (en) Novel treatment
PL349347A1 (en) Novel treatment
AU5547000A (en) Novel treatment
AU4556800A (en) Novel treatment
GB9906245D0 (en) Enzyme
AU5639700A (en) Targeted anticalcification treatment
HK1046913A1 (zh) 為治療傳染病的被縮小微生物
AU1972200A (en) Treatment for fabrics
GB9924634D0 (en) Enzyme
GB9908458D0 (en) Enzyme
GB9908993D0 (en) Treatment
GB9916655D0 (en) Novel treatment
GB9909650D0 (en) Novel treatment
GB9920788D0 (en) Novel treatment
GB9920787D0 (en) Novel treatment
GB9923343D0 (en) Treatment system
ZA200002170B (en) Treatment of acarids.
GB9903558D0 (en) Medical treatment
GB9923111D0 (en) Effluent treatment
AUPQ281499A0 (en) Treatment mat